AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Halma plc
Video analysis: HLMAF
All videosNo video analysis for this stock yet. Request one from our team.
News: HLMAF
Halma acquires US water monitoring specialist Pyxis for up to $200 million
Halma PLC (LSE: HLMA) has agreed to acquire water quality monitoring specialist Pyxis for an initial $170 million (£126 million), strengthening its Environmental & Analysis division. The FTSE 100 safety, health and environmental technology group reported a further earn-out of up to $30 million (£22 million) could be payable for the US-based business, depending on performance over the two financial years ending March 2028 and March 2029.
Halma (OTCMKTS:HLMAF) Shares Gap Up – Still a Buy?
Halma (OTCMKTS:HLMAF - Get Free Report)'s share price gapped up before the market opened on Friday. The stock had previously closed at $47.5230, but opened at $49.3210. Halma shares last traded at $49.3910, with a volume of 628 shares changing hands. Analysts Set New Price Targets Several equities analysts have commented on HLMAF shares.
Short Interest in Halma (OTCMKTS:HLMAF) Rises By 81.5%
Halma (OTCMKTS:HLMAF - Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 288,780 shares, a growth of 81.5% from the June 15th total of 159,111 shares. Currently, 0.1% of the company's shares are short sold. Based on an average trading
Halma continues dealmaking spree with pair of healthcare acquisitions
Halma PLC (LSE:HLMA) has struck a pair of healthcare acquisitions worth a combined £54 million, extending its dealmaking spree after its biggest ever year for acquisitions. The FTSE 100 safety equipment group said it had acquired Dutch hospital software business Itemedical for €23 million (about £20 million), and Sweden's Naslund Medical for $45 million (about £34 million).
Halma sell-off created an entry point some investors have been waiting for says analyst
Halma PLC's (LSE:HLMA) sharp post-results sell-off has created the “entry point” investors had been waiting for, according to UBS, which reiterated its Buy rating and 4,775p price target on the safety, healthcare and industrial technology group. The Swiss bank said the shares' 15% fall after the company's FY26 results and FY27 guidance looked like “a pure derating” rather than a deterioration in the investment case.
Similar companies
-
Grupo Carso, S.A.B. de C.V.
GPOVF
·
Other OTC
Compare
-
Poste Italiane S.p.A.
PITAF
·
Other OTC
Compare
-
Jardine Matheson Holdings Limited
JARLF
·
Other OTC
Compare
-
Vossloh AG
VOSSY
·
Other OTC
Compare
-
Keppel Corporation Limited
KPELY
·
Other OTC
Compare
-
ACS, Actividades de Construcción y Servicios, S.A.
ACSAF
·
Other OTC
Compare